Showing results (2311-2320 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|July 22, 2008
A phase I trial of PTK787/ZK222584 in combination with pemetrexed and cisplatin in patients with advanced solid tumorsSunil Sharma, Burgess Freeman, Jeanette Turner, et al.
Investigational New Drugs|August 11, 1991
Phase II trial of daily oral etoposide in patients with advanced non-small cell lung cancerS Saxman, P J Loehrer, K Logie, et al.
Investigational New Drugs|June 23, 2006
Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS)Revathi Suppiah, Laura Wood, Paul Elson, et al.
Investigational New Drugs|May 31, 2007
In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expressionAxel-Rainer Hanauske, Ulrike Eismann, Olaf Oberschmidt, et al.
Investigational New Drugs|April 19, 2007
Erlotinib and vinorelbine in advanced malignant solid tumors: a phase I studyAngela M Davies, Cheryl Ho, Paul J Hesketh, et al.
Investigational New Drugs|June 25, 2008
Effect of coadministration of ketoconazole, a strong CYP3A4 inhibitor, on pharmacokinetics and tolerability of motesanib diphosphate (AMG 706) in patients with advanced solid tumorsPatricia Lorusso, Elisabeth I Heath, Jesse McGreivy, et al.
Investigational New Drugs|May 10, 2006
A phase I study of flavopiridol and docetaxelBasil F El-Rayes, Shirish Gadgeel, Ralph Parchment, et al.
Investigational New Drugs|May 10, 2006
A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumorsWerner Hilgers, Sandrine Faivre, Stéphanie Chieze, et al.
Investigational New Drugs|December 6, 2006
Transport of a novel anti-cancer agent, fenretinide across Caco-2 monolayersAmit Kokate, Xiaoling Li, Bhaskara Jasti
Investigational New Drugs|December 6, 2006
Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinomaMatthew D Galsky, Svetlana Mironov, Alexia Iasonos, et al.
Pageof 372